Obesity-related cancer development occurs due to an imbalance in adipokines, characterized by increased production of leptin (oncogenic adipokine) and reduced release of adiponectin (anti-oncogenic adipokine) [1,25]. This evidence concerns the gene LEP and obesity disorder.